Knockdown of AKR1C3 Promoted Sorafenib Sensitivity Through Inhibiting the Phosphorylation of AKT in Hepatocellular Carcinoma

Overview of attention for article published in Frontiers in oncology, March 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 15 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 7,548 followers.

RT @FrontOncology: New research: Knockdown of AKR1C3 Promoted Sorafenib Sensitivity Through Inhibiting the Phosphorylation of AKT in Hepato…

01 Jul 2022

Reply Repost Favourite

New article: Knockdown of AKR1C3 Promoted Sorafenib Sensitivity Through Inhibiting the Phosphorylation of AKT in Hepatocellular Carcinoma https://t.co/APC1u8ttI9 #livercancer #oncology https://t.co/eiUJPSqftM

01 Apr 2022

Reply Repost Favourite

New research: Knockdown of AKR1C3 Promoted Sorafenib Sensitivity Through Inhibiting the Phosphorylation of AKT in Hepatocellular Carcinoma: Background Sorafenib, which can induce ferroptosis, is a multikinase inhibitor for enhancing survival… https://t.co

12 Mar 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.